EXELON CORP
$50.09
-1.01%
Exelon received a JPMorgan price target raise to $53, reflecting analyst confidence in the company's $41.3 billion four-year capital investment plan targeting 7.9% annual rate base growth across its six regulated utilities. The company serves approximately 10 million customers and benefits from constructive regulatory environments supporting large-scale infrastructure investments. Key risks include potential delays in regulatory rate case approvals and rising financing costs for the capital program in a higher interest rate environment.